Hopveus
Country: Unjoni Ewropea
Lingwa: Malti
Sors: EMA (European Medicines Agency)
Rapport ta 'Valutazzjoni Pubblika
(PAR)
13-07-2020
Xi dokumenti għal dan il-prodott mhumiex disponibbli bħalissa, tista 'tibgħat talba lis-servizz tal-konsumatur tagħna u aħna ninnotifikawkom malli nkunu nistgħu niksbuhom.
Ibgħat talba.
Ibgħat talba.
Ingredjent attiv:
sodium oxybate
Disponibbli minn:
D&A Pharma
Kodiċi ATC:
N07BB
INN (Isem Internazzjonali):
sodium oxybate
Grupp terapewtiku:
Drogi oħra tas-sistema nervuża
Żona terapewtika:
Substance Withdrawal Syndrome; Alcohol Abstinence
Indikazzjonijiet terapewtiċi:
Substitution treatment for alcohol dependence within a framework of careful medical supervision along with continuous psychosocial support and social rehabilitation. Treatment should be initiated only in patients resistant to existing interventions or in patients for whom existing therapies are contra-indicated or not recommended.
L-istatus ta 'awtorizzazzjoni:
Miċħuda
